Collections and calls for papers

Patients with cancer are generally considered to be at both higher thrombotic and higher bleeding risk than patients without cancer. At the same time, patients with cancer often require anti-thrombotic thera...

Antithrombotic medications remain the cornerstone in the management of cardiovascular disease. While currently available medications greatly reduce ischemic and thromboembolic risk in a number of conditions,...